Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (13)

2024

  1. Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)

    Medicina Clinica

2022

  1. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  2. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

  3. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 359-369

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Contemporary differences between men and women with acute coronary syndromes: CIAM multicenter registry

    Journal of Cardiovascular Medicine, Vol. 20, Núm. 8, pp. 525-530

2018

  1. Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE

    Europace, Vol. 20, Núm. 11, pp. 1719-1720

  2. The Role of Frailty in Acute Coronary Syndromes in the Elderly

    Gerontology, Vol. 64, Núm. 5, pp. 422-429

2017

  1. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486

  2. Frailty is an independent prognostic marker in elderly patients with myocardial infarction

    Clinical Cardiology, Vol. 40, Núm. 10, pp. 925-931

2016

  1. Frailty predicts major bleeding within 30 days in elderly patients with Acute Coronary Syndrome

    International Journal of Cardiology, Vol. 222, pp. 590-593

2012

  1. Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction

    American Heart Journal, Vol. 164, Núm. 4

  2. Síndrome de tako-tsubo e insuficiencia cardiaca: seguimiento a largo plazo

    Revista Espanola de Cardiologia, Vol. 65, Núm. 11, pp. 996-1002